Jingyu H. Zhang
406 Jiefang South Road
Tianjin, 300211, China
Tianjin, 300211, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Phenology-Dependent Sex Identification in Mature Ginkgo biloba Using Hyperspectral Imaging.
Journal: Plants (Basel, Switzerland)
Published: June 12, 2026
Targeting MD2 in diseases: from structure and function to inhibitor development.
Journal: European journal of medicinal chemistry
Published: May 11, 2026
A multi-omics atlas reveals a zf-C2H2-dominated regulatory hub governing embryonic development in Periplaneta americana.
Journal: Insect biochemistry and molecular biology
Published: December 21, 2025
Discovery and optimization of Menin-MLL inhibitors targeting acute myeloid leukemia.
Journal: European journal of medicinal chemistry
Published: October 17, 2025
Deficiency of NRF2 aggravates BLM-induced systemic sclerosis-associated fibrosis and inflammation in mice.
Journal: International immunopharmacology
Published: October 15, 2025
Modular PROTAC/IMiD Bifunctional Molecule Design for the Degradation of Synergistic Targets in the Treatment of Lymphoma.
Journal: Journal of medicinal chemistry
Published: October 14, 2025
Discovery of a Selective and Potent BCL6 PROTAC with Efficacious Antiproliferative Activity for the Treatment of Diffuse Large B-Cell Lymphoma.
Journal: Journal of medicinal chemistry
Published: September 30, 2025
Optimisation of Laser-Assisted Biopsy Parameters in Bovine Embryos.
Journal: Reproduction in domestic animals = Zuchthygiene
Published: September 24, 2025
AI search, physician removal: Bronchoscopy robot bridges collaboration in foreign body aspiration.
Journal: Science robotics
Published: July 30, 2025
ATP6V0D2 drives triple-negative breast cancer progression and inhibits cisplatin sensitivity by promoting PHLPP2 lysosomal degradation.
Journal: iScience
Published: June 11, 2025
Design, synthesis, and evaluation of Menin-targeting compounds for the treatment of acute Myelocytic leukemia (AML).
Journal: European journal of medicinal chemistry
Published: April 11, 2025
Rational engineering of degradation tail-driven CELMoD-antibody conjugates for precision malignancy therapy.
Journal: Acta pharmaceutica Sinica. B
Published: February 14, 2025
Last Updated: 09/26/2026